Technical Analysis for TSHA - Taysha Gene Therapies, Inc.

Grade Last Price % Change Price Change
grade D 19.31 -8.27% -1.74
TSHA closed down 8.27 percent on Wednesday, October 28, 2020, on 52 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical TSHA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 20 DMA Bullish -8.27%
Pocket Pivot Bullish Swing Setup -8.27%
Stochastic Reached Oversold Weakness -8.27%
Oversold Stochastic Weakness -8.27%
Older End-of-Day Gignals for TSHA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 10 hours ago
Fell Below Lower Bollinger Band about 10 hours ago
Fell Below Previous Day's Low about 10 hours ago
Lower Bollinger Band Support about 10 hours ago
Down 1 ATR about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taysha Gene Therapies, Inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the treatment of CLN1 disease; TSHA-102 for the treatment of Rett syndrome; TSHA-103 for the treatment of SLC6A1 haploinsufficiency disorder; and TSHA-104 for the treatment for Surfeit locus 1 deficiency. The company also has strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. Taysha Gene Therapies, Inc. was founded in 2019 and is based in Dallas, Texas.
Biotechnology Life Sciences Rare Diseases Gene Therapy Therapy Lipid Storage Disorders Deficiency Gm2 Gangliosidoses Gm2 Gangliosidosis Monogenic Diseases

Is TSHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.53
52 Week Low 18.16
Average Volume 213,355
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 20.61
10-Day Moving Average 20.64
Average True Range 1.74
ADX 0.0
+DI 13.13
-DI 16.79
Chandelier Exit (Long, 3 ATRs ) 19.57
Chandelier Exit (Short, 3 ATRs ) 23.38
Upper Bollinger Band 21.81
Lower Bollinger Band 19.40
Percent B (%b) -0.04
BandWidth 11.73
MACD Line -0.49
MACD Signal Line -0.27
MACD Histogram -0.223
Fundamentals Value
Market Cap 714.32 Million
Num Shares 37 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.28
Resistance 3 (R3) 22.51 21.74 21.79
Resistance 2 (R2) 21.74 20.99 21.63 21.62
Resistance 1 (R1) 20.53 20.52 20.15 20.30 21.45
Pivot Point 19.76 19.76 19.57 19.65 19.76
Support 1 (S1) 18.55 19.01 18.17 18.32 17.17
Support 2 (S2) 17.78 18.54 17.67 17.00
Support 3 (S3) 16.57 17.78 16.84
Support 4 (S4) 16.34